Blood Pressure Response to Hypoxia: Role of Nitric Oxide Synthase

American Journal of Hypertension

Volumn 16, Issue 12, 2003, Pages 1043-1048

  Barton, Cyril H ^a   Ni, Zhenmin ^a   Vaziri, Nosratola D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hypertension; Hypoxia, nitric oxide synthase

Indexed keywords

3 NITROTYROSINE; ARGININE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; ATMOSPHERIC PRESSURE; BLOOD PRESSURE; CONTROLLED STUDY; ENZYME REGULATION; ERYTHROCYTOSIS; HYPERTENSION; HYPOBARISM; HYPOXIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

EID: 0345059215     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2003.07.021     Document Type: Article

References (28)

1. Vaziri ND, Wang XQ: Sustained systemic hypertension induced by extended hypobaric hypoxia. Kidney Int 1996;49:1457-1463.
2. Ni Z, Bemanian S, Kivlighn S, Vaziri ND: Role of endothelin and nitric oxide imbalance in the pathogenesis of hypoxia-induced arterial hypertension. Kidney Int 1998;54:188-192.
3. Vaziri ND, Liang K, Ding Y: Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int 1999;56:1492-1498.
4. Vaziri ND, Ding Y, Sangha DS, Purdy RE: Upregulation of nitric oxide synthase by simulated microgravity potential cause of orthostatic intolerance. J Appl Physiol 2000;89:338-344.
5. Kone BC, Baylis C: Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol 1997;272:F561-F578.
6. Vallance P, Baylis C: Circulation and hemodynamics. Curr Opin Nephrol Hypertens 1997;6:49-50.
7. Star RA: Intrarenal localization of nitric oxide synthase isoforms and soluble guanylyl cyclase. Clin Exp Pharmacol Physiol 1997;24: 607-610.
8. Kone BC: Nitric oxide in renal health and disease. Am J Kidney Dis 1997;30:311-333.
9. Zeidel ML: Hormonal regulation of inner medullary collecting duct sodium transport. Am J Physiol 1993;265:F159-F173.
10. Hall JE, Guyton AC, Brands MW: Pressure-volume regulation in hypertension. Kidney Int Suppl 1996;55:S35-S41.
11. Higashi Y, Oshima T, Watanabe M, Matsuura H, Kajiyama G: Renal response to L-arginine in salt-sensitive patients with essential hypertension. Hypertension 1996;27:643-648.
12. Patel AR, Granger JP, Kirchner KA: L-arginine improves transmission of perfusion pressure to the renal interstitium in Dahl salt-sensitive rats. Am J Physiol 1994;266:R1730-R1735.
13. Mattson DL, Bellehumeur TG: Neural nitric oxide synthase in the renal medulla and blood pressure regulation. Hypertension 1996;28: 297-303.
14. Vallon V, Thomson S: Inhibition of local nitric oxide synthase increases homeostatic efficiency of tubuloglomerular feedback. Am J Physiol 1995;269:F892-F899.
15. Ikeda Y, Saito K, Kim JI, Yokoyama M: Nitric oxide synthase isoform activities in kidney of Dahl salt-sensitive rats. Hypertension 1995;26:1030-1034.
16. Simchon S, Manger W, Blumberg G, Brensilver J, Cortell S: Impaired renal vasodilation and urinary cGMP excretion in Dahl salt-sensitive rats. Hypertension 1996;27:653-657.
17. Nakanimshi K, Tajima F, Nakamura A, Yagura S, Ookawara T, Yamashita H, Suzuki K, Taniguchi N, Ohno H: Effects of hypobaric hypoxia on antioxidant enzymes in rats. J Physiol 1995;489:869-876.
18. Vaziri ND, Ni Z, Oveisi F, Liang K, Pandian R: Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 2002;39:135-141.
19. Schnackenberg CG, Wilcox CS: Two-week administration of tempol attenuates both hypertension and renal excretion 8-iso prostaglandin F2 alpha. Hypertension 1999;33:424-428.
20. Harada S, Tokunaga S, Momohara M, Masaki H, Tagawa T, Imaizumi T, Takeshia A: Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits. Circ Res 1993;72:511-516.
21. Toda N, Kitamura Y, Okamura T: Neural mechanism of hypertension by nitric oxide synthase inhibitor in dogs. Hypertension 1993; 21:3-8.
22. Ni Z, Oveisi F, Vaziri ND: Nitric oxide synthase isotope expression in salt-sensitive and salt resistant Dahl rats. Hypertension 1998;34: 558-569.
23. Vaziri ND, Ni Z, Tarnavsky-Hobbs DL: Effect of antioxidant therapy on blood pressure and nitric oxide synthase expression in hypertensive rats. Hypertension 2000;36:957-964.
24. Barton CH, Ni Z, Vaziri ND: Effect of severe aortic banding above the renal arteries on nitric oxide synthase isotope expression. Kidney Int 2001;59:654-661.
25. Vaziri ND, Ding Y: Compensatory upregulation of nitric oxide synthase isoforms in lead-induced hypertension: reversal by a superoxide dismutase-mimetic drug. J Pharmacol Exp Ther 2001;298: 679-685.
26. Vaziri ND, Ding Y, Ni Z: Nitric oxide synthase expression in the course of lead-induced hypertension. Hypertension 1991;34:558-562.
27. Vaziri ND, Wang XQ, Oveisi F, Rad B: Induction of oxidative stress by gluthathione depletion causes severe hypertension in normal rats. Hypertension 2000;36:142-146.
28. Vaziri ND, Ding Y, Sangha DS, Purdy RE: Upregulation of NOS by simulated microgravity, potential cause of orthostatic intolerance. J Appl Physiol 2000;89:338-344.